Table 1 Clinical characteristics of study subjects
From: Circulating survivin levels in healthy and asthmatic pregnancy
AP N = 28 | ANP N = 25 | HP N = 21 | HNP N = 29 | P value | |
|---|---|---|---|---|---|
FEV 1 ; L | 2.9 ± 0.4 | 2.8 ± 0.7 | ND | ND | 0.54 |
(% pred) | (90 ± 11) | (88 ± 18) | (0.66) | ||
FVC; L | 3.6 ± 0.5 | 3.7 ± 0.8 | ND | ND | 0.85 |
(% pred) | (99 ± 13) | (100 ± 15) | (0.68) | ||
FE NO ; ppb | 19 (8–115) | 19 (5–82) | ND | ND | 0.62 |
ACT | 20 (8–25) | 20 (9–25) | ND | ND | 0.76 |
ICS; BDP eq. | 200 (0–2000) | 400 (0–1000) | NA | NA | 0.25 |
Neonatal birth weight; g | 3548 ± 714 | NA | 3442 ± 320 | NA | 0.59 |
Apgar; 1 and 5 minutes | 9 and 10 | NA | 9 and 10 | NA | 0.27 and 0.95 |
Week of delivery | 39 (36–42) | NA | 39 (36–41) | NA | 0.44 |